SCHEMBL13813584

SCHEMBL13813584

COc1cc(BO)cc(OC)c1OC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.40
▸ SRC P12931 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ACHE P22303 1/20 0.34
▸ ERN1 O75460 1/20 0.34
▸ CA9 Q16790 1/20 0.33
▸ TUBB4A P04350 3/20 0.33
▸ TUBB P07437 3/20 0.33
▸ TUBA3C P0DPH7 3/20 0.33
▸ TUBA1B P68363 3/20 0.33
▸ TUBA4A P68366 3/20 0.33
▸ TUBB4B P68371 3/20 0.33
▸ TUBB3 Q13509 3/20 0.33
▸ TUBB2A Q13885 3/20 0.33
▸ TUBB8 Q3ZCM7 3/20 0.33
▸ TUBA3E Q6PEY2 3/20 0.33
▸ TUBA1A Q71U36 3/20 0.33
▸ TUBA1C Q9BQE3 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7899795 0.81 CYP3A4 (0.56) GAAALDH1A1MAPTCYP3A4ACHE
SCHEMBL13284182 0.74 TPMT (0.50) MAPTCYP3A4ACHEERN1CA9
SCHEMBL31507661 0.74 SRC (0.44) GAASRCALDH1A1MAPTCYP3A4
SCHEMBL4114610 0.74 GAA (0.42) GAASRCALDH1A1MAPTCYP3A4
SCHEMBL11334799 0.73 GAA (0.40) GAASRCALDH1A1MAPTCYP3A4
SCHEMBL4116122 0.73 GAA (0.40) GAASRCALDH1A1MAPTCYP3A4
SCHEMBL986919 0.72 TPMT (0.61) CA9TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20118746 0.71 PTGS2 (0.67) GAASRCALDH1A1TUBB4ATUBB
SCHEMBL5206243 0.70 GAA (0.38) GAASRCALDH1A1MAPTCYP3A4
SCHEMBL4039970 0.70 MAPT (0.47) GAAALDH1A1MAPTCYP3A4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143430-A1 ERYTHROPOIETIN PRODUCTION ACCELERATOR KOWA CO., LTD. (JP) 2009-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143430-A1 ERYTHROPOIETIN PRODUCTION ACCELERATOR EPOR, GHRHR, ARL1 GAA 3222/4885SRC 2126/4885ALDH1A1 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback